MAA
Matrix Asset Advisors Portfolio holdings
AUM
$1.08B
1-Year Est. Return
15.98%
1 Year Est. Return
+15.98%
AUM
$1.08B
AUM Growth
+$89.8M
(+9.1%)
Holding
112
Top Buys
| 1 | +$11.5M | |
| 2 | +$8.86M | |
| 3 | +$8.84M | |
| 4 |
Constellation Brands
STZ
|
+$5.24M |
| 5 |
Applied Materials
AMAT
|
+$4.39M |
Top Sells
| 1 | +$16.1M | |
| 2 | +$6.68M | |
| 3 | +$4.22M | |
| 4 |
PepsiCo
PEP
|
+$3.3M |
| 5 |
Bank of New York Mellon
BK
|
+$2.03M |
Sector Composition
| 1 | Financials | 25.57% |
| 2 | Technology | 20.1% |
| 3 | Healthcare | 9.18% |
| 4 | Communication Services | 8.1% |
| 5 | Consumer Discretionary | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Merck
MRK
$251B
| $241K | 0.02% |
2,870
-45
|
|
||
102
IBM
IBM
$282B
| $238K | 0.02% |
845
+5
|
|
||
103
Aon
AON
$74.3B
| $231K | 0.02% |
648
|
|
||
104
SKYX Platforms
SKYX
$233M
| $226K | 0.02% |
201,666
|
|
||
105
Compugen
CGEN
$141M
| $138K | 0.01% |
93,833
|
|
||
106
DocGo
DCGO
$93.9M
| $136K | 0.01% |
100,000
|
|
||
107
Marker Therapeutics
MRKR
$19.8M
| $13.4K | ﹤0.01% |
15,000
|
|
||
108
Bristol-Myers Squibb
BMY
$98.2B
| – | – |
-4,729
|
|
||
109
Colgate-Palmolive
CL
$63.5B
| – | – |
-2,383
|
|
||
|
PARA
110
DELISTED
Paramount Global Class B
PARA
| – | – |
-22,890
|
|
||
111
Union Pacific
UNP
$138B
| – | – |
-69,866
|
|
||
112
Philip Morris
PM
$241B
| – | – |
-1,229
|
|